Atherectomy is still the go-to treatment option for many clinicians, but p IVL appears to be gaining momentum as time goes on.
SANTA CLARA, Calif., June 08, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified ...
SANTA CLARA, Calif., Dec. 04, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex ...
A 50-patient study explores lithotripsy-assisted stenting for calcified left main coronary disease, reporting expansion and ...
FastWave Medical's laser intravascular lithotripsy system successfully fractured calcified coronary artery lesions in 30 ...
Financing supports clinical advancement and commercialization of the company’s dual-modality IVL platform, with proceeds funding peripheral commercial launch and coronary program development WAYNE, Pa ...
FastWave Medical, which is developing next-generation intravascular lithotripsy (IVL) technology, today announced positive interim results ...
Shockwave Medical, Inc. SWAV recently commercially launched the Shockwave M5+ peripheral intravascular lithotripsy (“IVL”) catheter. Commercial availability of the product in Europe and the United ...
SAN FRANCISCO — Two different balloon devices developed for the treatment of calcified coronary lesions were found noninferior to intravascular lithotripsy (IVL) at a lower cost in separate major ...
WASHINGTON--(BUSINESS WIRE)--Elixir Medical, a developer of disruptive technologies to treat cardiovascular disease, today announced positive six-month data from the PINNACLE I study evaluating the ...
SANTA CLARA, Calif., Dec. 04, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results